|
|
|
|
|
|
|||
| Research | Core Facilities | Patient Studies | Tech Transfer | Seminars | Intranet | Jobs | Search | Contact Us | Ways To Give HOME | |||
 |
||||
 |
Newsroom
Over the last 43 years, the Oklahoma chapter of the Ladies Auxiliary to the VFW has given more than $128,000 to OMRF. On Wednesday, the group visited OMRF to see the fruits of its investment. Twenty-six members, including National President Jan Tittle from South Carolina, toured the facility, met with scientists and spoke with OMRF President Stephen Prescott, M.D. “It is exciting to
see OMRF and to know, especially for the state members, that
there’s a facility so close by that’s doing this type of
cutting-edge research,” Tittle said. “I was especially
interested in OMRF’s autoimmune disease research, because my
husband has lupus.” A new study from OMRF has found that worms with an autism-related mutation are more susceptible to environmental toxins such as mercury, copper and paraquat. The researchers also found that the animals, which lacked a protein in the nervous system known as neuroligin, displayed sensory problems like those found in individuals with autism spectrum disorders. OMRF researchers James Rand, Ph.D., Gregory Mullen, Ph.D.,
and Jerrod Hunter published their findings this month in the
journal Disease Models and Mechanisms.
The problem with killing cancer is that it comes back. But new research from the Oklahoma Medical Research Foundation could pave the way for therapies that avoid this problem. The pre-clinical work has already shown promise in killing ovarian cancer cells. Researchers hope the approach, which stems drug resistance, might also prove effective in treating other forms of cancers. “When we use drugs to kill cancer, we almost never kill all
of it,” said OMRF scientist Amit Maiti, Ph.D. “And when the
cancer comes back, it’s resistant to the drug, which makes it
harder to kill.” Media Contact:
|
|
||
 Email this page
|
|
